Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant
Abdullah S. Al Saleh(Mayo Clinic), Morie A. Gertz(Medical University of South Carolina), David Dingli, Francis K. Buadi, Robert Christian Wolf(Heidelberg University), Nelson Leung(WinnMed), Shaji Kumar(Mayo Clinic), Prashant Kapoor, Christel Skaer(Mayo Clinic in Arizona), Sarah Wittwer(Mayo Clinic in Arizona), Rahma Warsame, Wilson I. Gonsalves(Mayo Clinic in Arizona), Taxiarchis Kourelis(Mayo Clinic in Arizona), Martha Q. Lacy(Mayo Clinic), Eli Muchtar(Mayo Clinic), William J. Hogan(Mayo Clinic), Jae‐Won Lee(Korea Research Institute of Bioscience and Biotechnology), Angela Dispenzieri(Mayo Clinic), Eapen Jacob(Mayo Clinic), M Hasib Sidiqi(Curtin University)
Cited by 13
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k